A U.S. District Court recently ruled against Zydus and Lupin, finding Astellas's patent for Myrbetriq was not invalid. Both ...

The litigation was initiated by Astellas Pharma against Zydus Lifesciences concerning the validity of the ‘780 patent’, which ...

Indian benchmark indices Nifty 50 and Sensex ended the previous trade session in the green. Nifty 50 closed at 23,437.20, ...

Global private equity firm Creador-backed company has approved pre-IPO placement of 8,98,735 equity shares for cash at a ...

Zydus Wellness Ltd., incorporated in the year 1994, is a Mid Cap company (having a market cap of Rs 10,994.04 Crore) operating in FMCG sector. Zydus Wellness Ltd. key Products/Revenue Segments include ...